Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU

被引：0
作者：
Roberta Joppi
Vittorio Bertele’
Silvio Garattini
机构：
[1] Mario Negri Institute for Pharmacological Research,Laboratory of Drug Regulatory Policies
[2] Local Health Unit of Verona,Pharmaceutical Department
来源：
European Journal of Clinical Pharmacology | 2013年 / 69卷
关键词：
Orphan drug; Rare disease; Pharmacological research; Drug regulation; Development; Preclinical studies; Clinical trials; Clinical efficacy; Placebo; Outcome measures;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1009 / 1024
页数：15
相关论文
共 50 条
  • [31] Involving Patients in Reducing Decision Uncertainties Around Orphan and Ultra-Orphan Drugs: A Rare Opportunity?
    Devidas Menon
    Tania Stafinski
    Andrea Dunn
    Hilary Short
    The Patient - Patient-Centered Outcomes Research, 2015, 8 : 29 - 39
  • [32] Providing Medical Information for Orphan Drugs
    Turbeville, Sean
    Wells, David A.
    Hornfeldt, Carl S.
    DRUG INFORMATION JOURNAL, 2012, 46 (01): : 88 - 93
  • [33] Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle
    Devidas Menon
    Tania Stafinski
    Andrea Dunn
    Durhane Wong-Rieger
    The Patient - Patient-Centered Outcomes Research, 2015, 8 : 103 - 117
  • [34] Developing a Patient-Directed Policy Framework for Managing Orphan and Ultra-Orphan Drugs Throughout Their Lifecycle
    Menon, Devidas
    Stafinski, Tania
    Dunn, Andrea
    Wong-Rieger, Durhane
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2015, 8 (01) : 103 - 117
  • [35] Mechanism of coordinated access to orphan drugs
    R DeRidder
    C Adriaens
    D Kleinermans
    M Mortier
    A Quanten
    F Arickx
    Orphanet Journal of Rare Diseases, 7 (Suppl 2)
  • [36] Legal and Regulatory Aspects of Orphan Drugs
    Shani, Segev
    Yahalom, Zohar
    PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2013, 11 : 110 - 115
  • [37] Providing Medical Information for Orphan Drugs
    Sean Turbeville
    David A. Wells
    Carl S. Hornfeldt
    Drug information journal : DIJ / Drug Information Association, 2012, 46 : 88 - 93
  • [38] Patient access to orphan drugs in France
    Marion Bourdoncle
    Blandine Juillard-Condat
    Florence Taboulet
    Orphanet Journal of Rare Diseases, 14
  • [39] Patient access to orphan drugs in France
    Bourdoncle, Marion
    Juillard-Condat, Blandine
    Taboulet, Florence
    ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
  • [40] Orphan drug policies and use in pediatric nephrology
    Diana Karpman
    Peter Höglund
    Pediatric Nephrology, 2017, 32 : 1 - 6
12345